CRSP CRISPR Therapeutics AG

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. CRISPR Therapeutics AG market cap is $4.89B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. CRISPR Therapeutics AG 52 week high is $91.10 as of July 26, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. CRISPR Therapeutics AG 52 week low is $37.55 as of July 26, 2024.

CRISPR Therapeutics AG stock price today is $57.92.

CRISPR Therapeutics AG stock price yesterday was $57.57.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. CRISPR Therapeutics AG’s P/E ratio is -21.15.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. CRISPR Therapeutics AG P/B ratio is 2.3437.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. CRISPR Therapeutics AG's EBITDA is -14.48.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. CRISPR Therapeutics AG 50-day moving average is $57.13.

CRISPR Therapeutics AG has 407 employees.